"FDA’s New Expert Panels Are Rife With Financial Conflicts And Fringe Views"
"When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert advisers who are carefully vetted for their independence, credentials and judgment. ... Instead, FDA Commissioner Marty Makary has launched a series of ad hoc 'expert panels' to discuss antidepressants, menopause drugs and other topics with physicians and researchers who often have contrarian views and financial interests in the subjects."











Advertisement 


